4318-79-0 Usage
Uses
Used in Pharmaceutical Industry:
PYRIDINE-2,3,6-TRIAMINE is used as a building block in the synthesis of pharmaceuticals and chemical intermediates, contributing to the development of new drugs and therapeutic agents.
Used in Antioxidant Applications:
PYRIDINE-2,3,6-TRIAMINE is studied for its potential as an antioxidant, which can help protect against oxidative stress and damage in various chemical and biological systems.
Used in Electronic Materials Industry:
PYRIDINE-2,3,6-TRIAMINE is investigated for its role in the development of materials for electronic applications, potentially enhancing the performance and functionality of electronic devices.
Used in Metal Extraction and Removal Processes:
PYRIDINE-2,3,6-TRIAMINE is utilized for its ability to chelate metal ions, making it useful in processes related to metal extraction and removal, which can be applied in various industrial and environmental contexts.
Check Digit Verification of cas no
The CAS Registry Mumber 4318-79-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,3,1 and 8 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 4318-79:
(6*4)+(5*3)+(4*1)+(3*8)+(2*7)+(1*9)=90
90 % 10 = 0
So 4318-79-0 is a valid CAS Registry Number.
InChI:InChI=1/C5H8N4/c6-3-1-2-4(7)9-5(3)8/h1-2H,6H2,(H4,7,8,9)
4318-79-0Relevant articles and documents
p38α AUTOPHOSPHORYLATION INHIBITORS
-
Page/Page column 34-35, (2020/07/07)
The present invention concerns inhibitors of p38α autophosphorylation, pharmaceutical compositions comprising them, and their use in the treatment of a number of diseases, such as myocardial ischemia reperfusion injury. The inhibitors satisfy the following general formula: wherein R, R1, R2, R4, and R5 may have different meanings.
NOVEL PYRIDOPYRAZINES AND USE THEREOF AS KINASE INHIBITORS
-
Page/Page column 16; 28-29, (2010/02/09)
The invention relates to novel pyrido[2,3-b]pyrazine derivatives of general formula (I), the production and use thereof as medicaments, especially for the treatment of malignant and other diseases based on pathological cell proliferations.